Literature DB >> 23225959

Metoclopramide-induced akathisia.

Gaurav Chauhan1, Pavan Nayar, Chandni Kashyap.   

Abstract

Entities:  

Year:  2012        PMID: 23225959      PMCID: PMC3511976          DOI: 10.4103/0970-9185.101967

Source DB:  PubMed          Journal:  J Anaesthesiol Clin Pharmacol        ISSN: 0970-9185


× No keyword cloud information.
Sir, A 45-year-old man, ASA physical status I, diagnosed with post-burn contracture of the right elbow joint, was scheduled for contracture release with split skin grafting. Examination showed a calm and cooperative man with unremarkable airway, chest, and cardiac findings. Patient was shifted to the preoperative room and monitoring of electrocardiogram, pulse oximetry, and blood pressure was started. Patient was administered oxygen via ventimask. Ranitidine 50 mg and metoclopramide 10 mg intravenous (IV) were administered as premedication. After 5 min, the patient developed an uneasy sensation, appeared restless and agitated, and exhibited movements of the arms and legs (crossing and uncrossing of the legs). He expressed a desire to move around and wanted to remove his IV cannula. He was immediately administered midazolam 1.5 mg IV. The symptoms subsided. He was monitored in recovery room for 30 min and subsequently shifted to the operation theater. General anesthesia was administered as per the standard protocol of our institute and the rest of the procedure proceeded uneventfully. Drug-induced akathisia (DIA) is often difficult to diagnose and may present with varying grades of severity. It is defined as a psychoneuromotor phenomenon in which the patient may describe an unpleasant feeling of inner restlessness or tension referable most commonly to the lower limbs, along with a desire to get up and walk, an inability to think clearly, and a feeling of anxiety. Most common offending agents are neuroleptic anti-psychotic medication or withdrawal from any physical addiction, e.g. benzodiazepine withdrawal syndrome.[1] The objective motor components include restlessness of the lower limbs in the form of rocking foot to foot, crossing and uncrossing of legs, and pacing.[1] Positron Emission Topography studies show D2 receptor occupancy in the striatum plays a role and noradrenergic and serotonergic systems also appear to be involved.[2] Interestingly, metoclopramide acts, in part, via presynaptic dopamine receptor antagonism, and an overactive adrenergic system secondary to presynaptic dopamine receptor block in key parts of the brain and spinal cord may be the possible mechanism of DIA.[2] Metoclopramide has been linked to akathisia in many reports and the incidence of restlessness reported after IV administration of drug is 20–25%.[3] The diagnosis of DIA is largely clinical. There are no relevant laboratory tests in making the diagnosis, as these patients may present in different ways, the condition may also mimic other clinical syndromes, or the symptoms may be masked by preoperative medication.[4] Once the diagnosis is made, the offending drug (in our case, metoclopramide) should be promptly withdrawn. Benzodiazepines, β-blockers, α2-agonists, opioids, and anti-cholinergics have all been used to treat akathisia.[5] Benzodiazepines are more effective in easing the symptoms of akathisia, but they are associated with higher sedation rates.[6] Our case highlights the importance of prompt recognition and treatment of metclopramide-induced akathisia. We believe that drugs commonly administered in the perioperative period have the potential of inducing akathisia.
  5 in total

Review 1.  The Barnes Akathisia Rating Scale--revisited.

Authors:  Thomas R E Barnes
Journal:  J Psychopharmacol       Date:  2003-12       Impact factor: 4.153

2.  Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.

Authors:  L Farde; A L Nordström; F A Wiesel; S Pauli; C Halldin; G Sedvall
Journal:  Arch Gen Psychiatry       Date:  1992-07

3.  Clinical characteristics and predisposing factors in acute drug-induced akathisia.

Authors:  P Sachdev; J Kruk
Journal:  Arch Gen Psychiatry       Date:  1994-12

Review 4.  Metoclopramide-induced movement disorders. Clinical findings with a review of the literature.

Authors:  L G Miller; J Jankovic
Journal:  Arch Intern Med       Date:  1989-11

5.  Midazolam vs. diphenhydramine for the treatment of metoclopramide-induced akathisia: a randomized controlled trial.

Authors:  Ismet Parlak; Bulent Erdur; Mine Parlak; Ahmet Ergin; Cuneyt Ayrik; Onder Tomruk; Ibrahim Turkcuer; Nesrin Ergin
Journal:  Acad Emerg Med       Date:  2007-05-31       Impact factor: 3.451

  5 in total
  2 in total

1.  Clinical Consequences of Motor Behavior as Transdiagnostic Phenomenon.

Authors:  Peter N Van Harten; Lydia E Pieters
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

2.  "Phantom akathisia" in an amputated leg of a sarcoma patient: a case report.

Authors:  Mayumi Ishida; Jungo Imanishi; Yasuo Yazawa; Yu Sunakawa; Tomoaki Torigoe; Hideki Onishi
Journal:  Biopsychosoc Med       Date:  2020-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.